{
    "nctId": "NCT04438681",
    "briefTitle": "Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer Patients",
    "officialTitle": "INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer Patients",
    "overallStatus": "RECRUITING",
    "conditions": "Triple Negative Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 90,
    "primaryOutcomeMeasure": "Identification at diagnosis of a plasma protein profile predictive of metastatic relapse in patients with triple-negative breast cancer (TNBC)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female\n* Age \\> 18 years\n* Diagnosed with primitive, non-metastatic, histologically proved, triple negative breast cancer\n* Patient able to understand the French language\n* Patient affiliated to social security\n* Obtaining signed written consent\n\nExclusion Criteria:\n\n* Persons deprived of their freedom or under guardianship or incapable of giving consent\n* Refusal to participate",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}